Agios Pharmaceuticals (AGIO): Volume dana dhuwit perusahaan

AGIO (Agios Pharmaceuticals Inc) - tandha merek perusahaan

Agios Pharmaceuticals specializes in the therapy of metabolic disorders and rare blood pathologies. Current cash reserves demonstrate liquidity dynamics, where the 0.63 level reflects the current amount of capital. The orphan status of the drugs guarantees market protection, while outsourcing production to third-party contractors reduces costs. Meanwhile, the company's environmental policy is formal in nature, limited to laboratory cleanliness standards.

AGIO - Posisi dhuwit perusahaan Agios ing rentang 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Agios (AGIO)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:Agios Pharmaceuticals AGIO
Produk mawa merek Agios Pharmaceuticals, Inc.

Cash reserve dynamics on the GURU.Markets platform reflect the ability of Agios Pharmaceuticals (AGIO) to fund expansion within the rare blood disease segment and acquire new metabolic molecules. This indicator measures the volume of liquid assets, determining the degree of financial autonomy and the business's protection from external borrowing, which allows investors to assess the balance between conservative resource accumulation and the company's capitalization rates.

Pesaing langsung

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Structure Pharma - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)